USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer
Publication date: | 2017 |
Publisher version: | http://dx.doi.org/10.1074/jbc.M116.762757 |
Citación: | Journal Of Biological Chemistry, 292(10), p. 4164-4175 (2017); doi:10.1074/jbc.M116.762757 |
Descripción física: | p. 4164-4175 |
Patrocinado por: |
Principado de Asturias, Spain; National Institutes of Health Grant [CA140474]; American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital; Ministerio de Economia y Competitividad; Instituto de Salud Carlos III (CIBERONC, Plan Feder); Fundacion EDP This work was supported by grants from the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (CIBERONC, Plan Feder), Fundacion EDP, and Principado de Asturias, Spain. The discovery and synthesis of sudemycin D1 and D6 were supported in part by National Institutes of Health Grant CA140474, the American Lebanese Syrian Associated Charities (ALSAC), and St. Jude Children's Research Hospital. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
Collections
- Artículos [27603]